AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 25-A-07-043.04
We recommend that the West Virginia Bureau for Medical Services strengthen internal controls for non-crossover claims going forward, to better use…
The recommendation, in the publisher's words
We recommend that the West Virginia Bureau for Medical Services strengthen internal controls for non-crossover claims going forward, to better use collected data to invoice manufacturers and collect rebates for all eligible physician-administered drugs.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- February 4, 2025
- Report
- West Virginia Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs (A-07-23-06109) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Partial Concur (as recorded by the publisher)
- Last update received
- October 6, 2026
- Next update expected
- May 5, 2027 (publisher's date)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
- Next update expected changed from “October 13, 2026” to “May 5, 2027”. (observed by AuditLine in the publisher's file)
- Last update received changed from “April 13, 2026” to “October 6, 2026”. (observed by AuditLine in the publisher's file)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
4 more, of which 3 are open in the publisher's file.
- We recommend that the West Virginia Bureau for Medical Services refund to the Federal Government $2,159,071 (Federal share) for claims for single-source physician-administered drugs that…HHS OIG 25-A-07-043.01 · issued Feb 4, 2025Open Unimplemented
- We recommend that the West Virginia Bureau for Medical Services refund to the Federal Government $14,514 (Federal share) for claims for top-20 multiple-source physician-administered drugs…HHS OIG 25-A-07-043.02 · issued Feb 4, 2025 · closed Apr 13, 2026Closed Implemented
- We recommend that the West Virginia Bureau for Medical Services work with CMS to determine the unallowable portion of $488,185 (Federal share) for other claims for multiple-source…HHS OIG 25-A-07-043.03 · issued Feb 4, 2025Open Unimplemented
- We recommend that the West Virginia Bureau for Medical Services consider revising its payment methodology going forward regarding payments for crossover claims, thereby allowing collection…HHS OIG 25-A-07-043.05 · issued Feb 4, 2025Open Unimplemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.